pyruvaldehyde has been researched along with liraglutide in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hölscher, C; Jalewa, J; Sharma, MK | 1 |
| Hammes, HP; Humpert, PM; Klein, T; Lin, J; Morcos, M; Schlotterer, A; Wongchai, K | 1 |
| Andreozzi, F; Beguinot, F; Davalli, AM; Folli, F; Mannino, GC; Miele, C; Nigro, C; Procopio, T; Raciti, GA; Sesti, G | 1 |
| Bianchi, M; Braghini, MR; D'Oria, V; Manco, M; Petrini, S | 1 |
| Chen, Z; Gao, R; Lin, D; Lin, L; Liu, L; Liu, X; Liu, Z; Qi, L; Wang, L | 1 |
5 other study(ies) available for pyruvaldehyde and liraglutide
| Article | Year |
|---|---|
Neuroprotective and anti-apoptotic effects of liraglutide on SH-SY5Y cells exposed to methylglyoxal stress.
Topics: Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Blotting, Western; Calcium; Caspase 3; Cell Line; Cell Proliferation; Cell Survival; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Immunohistochemistry; Liraglutide; Membrane Potentials; Membrane Proteins; Mitochondrial Proteins; Mitogen-Activated Protein Kinases; Neuroprotective Agents; Oncogene Protein v-akt; Pyruvaldehyde; Receptors, Glucagon; Stress, Physiological | 2014 |
Protective Effects of Liraglutide and Linagliptin in C. elegans as a New Model for Glucose-Induced Neurodegeneration.
Topics: Animals; Antioxidants; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Dose-Response Relationship, Drug; Forkhead Transcription Factors; Glucose; Glycation End Products, Advanced; Linagliptin; Liraglutide; Longevity; Models, Biological; Nerve Degeneration; Neuroprotective Agents; Proto-Oncogene Proteins c-akt; Pyruvaldehyde; Reactive Oxygen Species | 2016 |
The GLP-1 receptor agonists exenatide and liraglutide activate Glucose transport by an AMPK-dependent mechanism.
Topics: AMP-Activated Protein Kinases; Animals; Biological Transport; Cell Line; Deoxyglucose; Enzyme Activation; Exenatide; Gene Expression Profiling; Gene Silencing; Glucagon-Like Peptide-1 Receptor; Glucose; Humans; Insulin Resistance; Liraglutide; Mice; Muscle Fibers, Skeletal; Papio; Peptides; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyruvaldehyde; Rats; Signal Transduction; Time Factors; Venoms | 2016 |
Liraglutide Treatment Ameliorates Neurotoxicity Induced by Stable Silencing of Pin1.
Topics: Adenosine Triphosphate; Apoptosis; Cell Line, Tumor; Deoxyglucose; Gene Silencing; Humans; Insulin; Liraglutide; Neurons; Neuroprotective Agents; NIMA-Interacting Peptidylprolyl Isomerase; Nuclear Respiratory Factor 1; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Pyruvaldehyde; Reactive Oxygen Species; Sirtuin 1 | 2019 |
Liraglutide reduces oxidative stress and improves energy metabolism in methylglyoxal-induced SH-SY5Y cells.
Topics: Energy Metabolism; Glucose; Humans; Hypoglycemic Agents; Liraglutide; Neuroblastoma; Neurodegenerative Diseases; Neuroprotective Agents; Oxidative Stress; Pyruvaldehyde; Reactive Oxygen Species; Superoxide Dismutase | 2022 |